Warning: The NCBI web site requires JavaScript to function. more...
Thrombelastography and sepsis.
Puana R, Nates JL.
Crit Care. 2007;11(2):409; author reply 409. No abstract available.
Related citations
Antithrombin and hypercoagulability in sepsis: insights from thrombelastography?
Hoffmann JN, Schick K.
Crit Care. 2007;11(1):115.
Thromboelastometry in patients with severe sepsis and disseminated intravascular coagulation.
Sivula M, Pettilä V, Niemi TT, Varpula M, Kuitunen AH.
Blood Coagul Fibrinolysis. 2009 Sep;20(6):419-26.
Antithrombin III and sepsis.
Mammen EF.
Intensive Care Med. 1998 Jul;24(7):649-50. Review. No abstract available.
Antithrombin for severe sepsis? Try it again, but without heparin!
Jilma B.
Thromb Haemost. 2006 May;95(5):755. No abstract available.
[Antithrombin III in intensive therapy].
Baudo F, Caimi TM, Decataldo F, Calori G.
Minerva Anestesiol. 1999 Jan-Feb;65(1-2 Suppl 1):71-6. Review. Italian. No abstract available.
[Reactive thrombocytosis: on the importance of hemostasis monitoring].
Pérez Ferrer A, Gredilla Díaz E, de Vicente Sánchez J, Laporta Báez Y.
Rev Esp Anestesiol Reanim. 2009 Dec;56(10):645-6. Spanish. No abstract available.
The response of antithrombin III activity after supplementation decreases in proportion to the severity of sepsis and liver dysfunction.
Hayakawa M, Sawamura A, Yanagida Y, Sugano M, Hoshino H, Gando S.
Shock. 2008 Dec;30(6):649-52.
Thromboelastography should be available in every labour ward.
Hunt BJ, Lyons G.
Int J Obstet Anesth. 2005 Oct;14(4):324-5. No abstract available.
Watson HG.
Int J Obstet Anesth. 2005 Oct;14(4):325-7. No abstract available.
[Antithrombin III in the treatment of sepsis-- new approaches to prescribing the old drug].
Galstian GM, Shutova NA, Gorodetskiĭ VM.
Anesteziol Reanimatol. 2007 Nov-Dec;(6):66-71. Review. Russian. No abstract available.
Thrombophilia and outcome in severe infection and sepsis.
Hofstra JJ, Schouten M, Levi M.
Semin Thromb Hemost. 2007 Sep;33(6):604-9. Review.
Activity-guided antithrombin III therapy in severe surgical sepsis: efficacy and safety according to a retrospective data analysis.
Moubarak P, Zilker S, Wolf H, Hofner B, Kneib T, Küchenhoff H, Jauch KW, Hartl WH.
Shock. 2008 Dec;30(6):634-41.
Thrombophilia of nephrotic syndrome in adults.
Bramham K, Hunt BJ, Goldsmith D.
Clin Adv Hematol Oncol. 2009 Jun;7(6):368-72. Review. No abstract available.
Laboratory investigation of hypercoagulability in cancer patients using rotation thrombelastography.
Akay OM, Ustuner Z, Canturk Z, Mutlu FS, Gulbas Z.
Med Oncol. 2009;26(3):358-64. Epub 2008 Nov 20.
TEG and perioperative hypercoagulability.
Pivalizza EG.
Anesth Analg. 2006 Jan;102(1):334-5; author reply 335. No abstract available.
The limitations of observational studies on the treatment of severe sepsis.
Wiedermann CJ.
Crit Care. 2002 Dec;6(6):546-7; author reply 548. No abstract available.
Thrombophilia in the infant and child.
Manco-Johnson MJ, Nuss R.
Adv Pediatr. 2001;48:363-84. Review. No abstract available.
The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial.
Abou-Nassar K, Kovacs MJ, Kahn SR, Wells P, Doucette S, Ramsay T, Clement AM, Khurana R, Mackinnon K, Blostein M, Solymoss S, Kingdom J, Sermer M, Rey E, Rodger M; TIPPS investigators.
Thromb Haemost. 2007 Jul;98(1):163-71.
Antithrombotic therapies for sepsis: a need for more studies.
Minneci PC, Deans KJ, Cui X, Banks SM, Natanson C, Eichacker PQ.
Crit Care Med. 2006 Feb;34(2):538-41. Review. No abstract available.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on